06:22 AM EDT, 07/17/2025 (MT Newswires) -- Elevance Health ( ELV ) reported Q2 adjusted earnings Thursday of $8.84 per diluted share, down from $10.30 a year earlier.

Analysts surveyed by FactSet expected $8.91.

Total revenue for the quarter ended June 30 was $49.78 billion, up from $43.89 billion

Analysts surveyed by FactSet expected $48.19 billion.

For 2025, the health care provider cut its adjusted EPS forecast to $30 from the prior estimate of between $34.15 and $34.85. Analysts polled by FactSet expect $34.14.

Shares of the company fell more than 7% in recent premarket activity Thursday.

Price: 320.02, Change: -24.53, Percent Change: -7.12